Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis. (Record no. 5126)

MARC details
000 -LEADER
fixed length control field 03712nam a22003737a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200709s20202020 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0195-668X
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.1093/eurheartj/ehaa051 [doi]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 5762637 [pii]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code PMC7205467 [pmc]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 32112560
245 ## - TITLE STATEMENT
Title Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis.
251 ## - Source
Source European Heart Journal. 41(18):1733-1743, 2020 May 07.
252 ## - Abbreviated Source
Abbreviated source Eur Heart J. 41(18):1733-1743, 2020 May 07.
253 ## - Journal Name
Journal name European heart journal
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2020
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2020
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status ppublish
266 ## - Date added to catalog
Date added to catalog 2020-07-09
501 ## - WITH NOTE
Local holdings Available online from MWHC library: 1996 - present (after 1 year), Available in print through MWHC library: 1999 - 2006
520 ## - SUMMARY, ETC.
Abstract AIMS: Myocarditis is a potentially fatal complication of immune checkpoint inhibitors (ICI). Sparse data exist on the use of cardiovascular magnetic resonance (CMR) in ICI-associated myocarditis. In this study, the CMR characteristics and the association between CMR features and cardiovascular events among patients with ICI-associated myocarditis are presented.
520 ## - SUMMARY, ETC.
Abstract CONCLUSION: These data suggest caution in reliance on LGE or a qualitative T2-STIR-only approach for the exclusion of ICI-associated myocarditis. Copyright Published on behalf of the European Society of Cardiology. All rights reserved. (c) The Author(s) 2020. For permissions, please email: [email protected].
520 ## - SUMMARY, ETC.
Abstract METHODS AND RESULTS: From an international registry of patients with ICI-associated myocarditis, clinical, CMR, and histopathological findings were collected. Major adverse cardiovascular events (MACE) were a composite of cardiovascular death, cardiogenic shock, cardiac arrest, and complete heart block. In 103 patients diagnosed with ICI-associated myocarditis who had a CMR, the mean left ventricular ejection fraction (LVEF) was 50%, and 61% of patients had an LVEF >=50%. Late gadolinium enhancement (LGE) was present in 48% overall, 55% of the reduced EF, and 43% of the preserved EF cohort. Elevated T2-weighted short tau inversion recovery (STIR) was present in 28% overall, 30% of the reduced EF, and 26% of the preserved EF cohort. The presence of LGE increased from 21.6%, when CMR was performed within 4 days of admission to 72.0% when CMR was performed on Day 4 of admission or later. Fifty-six patients had cardiac pathology. Late gadolinium enhancement was present in 35% of patients with pathological fibrosis and elevated T2-weighted STIR signal was present in 26% with a lymphocytic infiltration. Forty-one patients (40%) had MACE over a follow-up time of 5 months. The presence of LGE, LGE pattern, or elevated T2-weighted STIR were not associated with MACE.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element IN PROCESS -- NOT YET INDEXED
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Heart & Vascular Institute
657 ## - INDEX TERM--FUNCTION
Medline publication type Journal Article
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Barac, Ana
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Forrestal, Brian J
790 ## - Authors
All authors Alvi RM, Armanious M, Awadalla M, Baksi AJ, Barac A, Chen CL, Coelho-Filho OR, Cohen JV, Damrongwatanasuk R, Ederhy S, Forrestal BJ, Fradley MG, Ganatra S, Golden DLA, Groarke JD, Gupta D, Hassan MZO, Heinzerling LM, Jones-O'Connor M, Kirchberger MC, Kwong RY, Lawrence DP, Lyon AR, Mahmood SS, Mahmoudi M, Mercurio V, Moslehi JJ, Mulligan C, Murphy SP, Neilan TG, Nohria A, Reynolds KL, Rizvi MA, Rokicki A, Sahni G, Stone JR, Sullivan RJ, Thavendiranathan P, Thuny F, Tocchetti CG, Weinsaft JW, Yang EH, Zhang L, Zlotoff DA
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.1093/eurheartj/ehaa051">https://dx.doi.org/10.1093/eurheartj/ehaa051</a>
Public note https://dx.doi.org/10.1093/eurheartj/ehaa051
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 07/09/2020   32112560 32112560 07/09/2020 07/09/2020 Journal Article

Powered by Koha